Table 1
Cross-cultural adaptation (phases and steps leading to adapted and validated QoL tool).
| Phase I |
|
| Phase II | The pilot phase consisted of submitting NOSE-si to a limited number (n=33) of patients in the study group and control group. Patient and expert comments with results were reevaluated by an expert committee and a preliminary statistical analysis was done to compare the pilot version of NOSE-si to the original tool and other CCA processed NOSE questionnaires (13, 16). Since high degree of internal consistency reliability was found, the expert committee accepted NOSE-si as the final version. |
| Phase III | Both the study and control group were enrolled. Retesting was scheduled 7-14 days after the initial testing for the study group and controls (90 patients). Patients had to fill out the same questionnaire and send it back to the researchers. |
| Phase IV | The postintervention test in the study group (90 days after surgery - submucosal resection of nasal septum). |
Table 2
NOSE (the original questionnaire).
| Not a problem | Very mild problem | Moderate problem | Fairly bad problem | Severe problem | |
|---|---|---|---|---|---|
| Nasal congestion or stuffiness | 0 | 1 | 2 | 3 | 4 |
| Nasal blockage or obstruction | 0 | 1 | 2 | 3 | 4 |
| Trouble breathing through my nose | 0 | 1 | 2 | 3 | 4 |
| Trouble sleeping | 0 | 1 | 2 | 3 | 4 |
| Unable to get enough air through my nose during exercise or exertion | 0 | 1 | 2 | 3 | 4 |
Table 3
Clinical characteristics of study patients.
| Study group (with complaints) (n=58) | Control group (no complaints) (n=58) | P value (study vs. control) | |
|---|---|---|---|
| Sex | |||
| Male | 15 (25.7%) | 27 (46.6%) | |
| Female | 43 (74.3%) | 31 (53.4%) | 0.004‡‡ |
| Age (y) | 37.8 (± 13.92) | 40.1 (± 14.43) | 0.452* |
| Body mass index (BMI) | 25.21 (± 4.19) | 22.85 (± 3.86) | 0.003* |
| Smokers | 16 (27.6%) | 14 (24.1%) | 0.832‡‡ |
| Mean NOSE-si score | 70.52 (± 15.46) | 3.97 (± 5.9) | <0.001** |
Table 4
NOSE-si correlation (inter-item and item-total correlation; original NOSE field names are used).
| Inter-Item Correlation Matrix | |||||
|---|---|---|---|---|---|
| Nasal congestion or stuffiness | Nasal blockage or obstruction | Trouble breathing through my nose | Trouble sleeping | Unable to get enough air through my nose during exercise or exertion | |
| Nasal congestion or stuffiness | 1.000 | 0.916 | 0.899 | 0.822 | 0.881 |
| Nasal blockage or obstruction | 0.916 | 1.000 | 0.909 | 0.844 | 0.887 |
| Trouble breathing through my nose | 0.899 | 0.909 | 1.000 | 0.851 | 0.875 |
| Trouble sleeping | 0.822 | 0.844 | 0.851 | 1.000 | 0.800 |
| Unable to get enough air through my nose during exercise or exertion | 0.881 | 0.887 | 0.875 | 0.800 | 1.000 |
| Item-Total Statistics | |||||
|---|---|---|---|---|---|
| Scale Mean if Item Deleted | Scale Variance if Item Deleted | Corrected Item-Total Correlation | Squared Multiple Correlation | Cronbach’s Alpha if Item Deleted | |
| Nasal congestion or stuffiness | 6.02 | 32.208 | 0.929 | 0.875 | 0.961 |
| Nasal blockage or obstruction | 5.91 | 32.027 | 0.942 | 0.892 | 0.959 |
| Trouble breathing through my nose | 5.92 | 31.933 | 0.934 | 0.875 | 0.960 0.971 |
| Trouble sleeping | 6.09 | 32.800 | 0.864 | 0.755 | 0.965 |
| Unable to get enough air through my nose during exercise or exertion | 5.84 | 32.567 | 0.905 | 0.828 | |

Figure 1
Effect size estimate (the left side showing large discrimination, the right side showing efficacy of intervention).
